⚠ EN DIRECT — European Consumer Safety Watch 💊 Médicaments: 16 au cours des 7 derniers jours 🍎 Alimentation: 193 au cours des 7 derniers jours 🧸 Produits: 48 au cours des 7 derniers jours 🟢 Surveillance: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Dernière récupération: il y a 2 heures ⚠ EN DIRECT — European Consumer Safety Watch 💊 Médicaments: 16 au cours des 7 derniers jours 🍎 Alimentation: 193 au cours des 7 derniers jours 🧸 Produits: 48 au cours des 7 derniers jours 🟢 Surveillance: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Dernière récupération: il y a 2 heures
🛡️ EUSW
🇫🇷
💊

SonoVue

sulphur hexafluoride
Échographie;Échocardiographie
✅ Autorisé
Aucune alerte active
Ce médicament ne fait l'objet ni de pénuries en cours, ni de lettres de sécurité, ni de rappels.

À quoi ça sert

This medicinal product is for diagnostic use only. SonoVue is for use with ultrasound imaging to enhance the echogenicity of the blood, or of fluids in the urinary tract which results in an improved signal to noise ratio. SonoVue should only be used in patients where study without contrast enhancement is inconclusive. Echocardiography SonoVue is a transpulmonary echocardiographic contrast agent for use in adult patients with suspected or established cardiovascular disease to provide opacification of cardiac chambers and enhance left ventricular endocardial border delineation. Doppler of macrovasculature SonoVue increases the accuracy in detection or exclusion of abnormalities in cerebral arteries and extracranial carotid or peripheral arteries in adult patients by improving the Doppler signal to noise ratio. SonoVue increases the quality of the Doppler flow image and the duration of clinically useful signal enhancement in portal vein assessment in adult patients. Doppler of microvasculature SonoVue improves display of the vascularity of liver and breast lesions during Doppler sonography in adult patients leading to more specific lesion characterisation. Ultrasonography of excretory urinary tract SonoVue is indicated for use in ultrasonography of the excretory tract in paediatric patients from newborn to 18 years to detect vesicoureteral reflux. For the limitation in the interpretation of a negative urosonography.

⚠️ Sécurité des patients

No

⚠️ Nous agrégeons des avis officiels. Nous ne donnons pas d'avis médical. Pour toute décision médicale ou juridique, consultez l'agence source et un professionnel qualifié.